Outpatient ertapenem therapy in an ESBL-high-prevalence area: an efficacy, safety, and cost study

Overview of attention for article published in Infection and Drug Resistance, December 2018

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 622 followers.

Outpatient ertapenem therapy in an ESBL-high-prevalence area: an efficacy, safety, and cost study. https://t.co/bxP4M4glOw #cre #crkp #AMR

Outpatient ertapenem therapy in an ESBL-high-prevalence area: an effic | IDR - Dove Medical Press https://t.co/oZOZBvxR6g #cre #crkp #AMR